Intratumoral lipids in 1H MRS is vivo in brain tumors: Experience of the Siemens Cooperative Clinical Trial

Anticancer Research

Volumn 16, Issue 3 B, 1996, Pages 1533-1538

  Negendank, William ^a   Sauter, Rolf ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b SIEMENS AG   (Germany)

Author keywords

Glioma; Lipids; Magnetic resonance spectroscopy; Neoplasm

Indexed keywords

CHOLINE; FATTY ACID; LIPID; LACTIC ACID; LACTIC ACID DERIVATIVE;

ASTROCYTOMA; BRAIN TUMOR; CANCER GRADING; CELL DEATH; CONFERENCE PAPER; EPENDYMOMA; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MENINGIOMA; NECROSIS; NEUROECTODERM TUMOR; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; LIPID METABOLISM; METABOLISM; REVIEW;

ASTROCYTOMA; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; LACTATES; LACTIC ACID; LIPID METABOLISM;

EID: 0029666215     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. 1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR Biomed 7:149-155, 1994.
2. 1H MR spectroscopy. NMR Biomed 7: 172-180, 1994.
3. Nelson JS, Tsukada Y, Schoenfeld D, Fulling K, Lamarche J and Peress N: Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas. Cancer 52: 550-554, 1983.
4. Burger PC, Vogel FS, Green SB and Strike TA: Glioblastoma multiforme and anaplastic astrocytoma: Pathologic criteria and prognostic implications. Cancer 56: 1106-1111, 1985.
5. Frahm, J, Bruhn H, Haenicke W, Merboldt K-D, Mursch K and Markakis E: Localized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences. J Comput Assist Tomogr 15: 915-922, 1991.
6. Posse S, Schuknecht B, Smith ME, van Zijl PCM, Herschkowitz N and Moonen CTW: Short echo time proton MR spectroscopic imaging. J Comput Assist Tomogr 17: 1-14, 1993.
7. Tzika AA, Vigneron DB, Ball WS, Dunn RS and Kirks DR: Localized proton MR spectroscopy of the brain in children. J Magn Reson Imag 3: 719-729, 1993.
8. 1H NMR spectrum of rat brain. Magn Reson Med 30: 38-40, 1993.
9. 1H NMR spectroscopy. J Neurochem 64: 1655-1661, 1991
10. Furuya S, Naruse S, Ide M, Murakami K, Miyazaki T and Yamamoto T: The clinical application of multi-voxel IH-CSI (chemical shift imaging) in brain tumors. Nippon Acta Radiologica 51: 836-838, 1991.
11. Heesters MAAM, Kamman RL, Mooyaart EL and Go KG: Localized proton spectroscopy of inoperable brain gliomas: Response to radiation therapy. J Neurooncol 17: 27-35, 1993.
12. Herholz K, Heindel W, Luyten PR, den Hollander JA, Pietrzyk U, Voges J, Kugel H, Friedmann G and W-D Heiss: In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann Neurol 31: 319-327, 1992.
13. Negendank W, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, Heerschap A, Kamada K, Lee BCP, Mengeot MM, Moser E, Padavic-Shaller KA, Sanders JA, Spraggins TA, Stillman AE, Terwey B, Vogl TJ. Wicklow K and Zimmerman RA: Proton MR spectroscopy in patients with glial tumors: A multicenter study. J Neurosurgery 84: 449-458, 1996.
14. Ott D, Hennig J, Ernst T: Human brain tumors: Assessment with in vivo proton MR spectroscopy. Radiology 186: 745-752, 1993.
15. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System. Second Edition. Berlin: Springer-Verlag, 1993.
16. Freitas I, Pontiggia P, Barni S, Bertone V, Parente M, Novarina A, Roveta G, Gerzeli G and Steward P: Histochemical probes for the detection of hypoxic tumour cells. Anticancer Res 10: 613-622, 1990.
17. Schick F, Naegele T, Klose U, Lutz O: Lactate quantification by means of PRESS spectroscopy - Influence of refocusing pulses and timing scheme. Magn Reson Imaging 13: 309-319, 1995.
18. Kugel H, Heindel W, Ernestus R-I, Bunke J, du Mesnil R and Friedmann G: Human brain tumors: Spectral patterns detected with localized H-1 MR spectroscopy. Radiology 183: 701-709, 1992.
19. Fulham MJ, Bizzi A, Dietz MJ, Shih MJ, Raman R, Sobering GS, Frank JA, Dwyer AJ, Alger JR and Dichiro G: Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance. Radiology 185: 675-686, 1992.
20. Russell DS, Rubinstein LJ: Pathology of tumors of the nervous system, 4th edition. Baltimore: Williams & Wilkins, 1977.
21. Winger MJ, MacDonald DR, Cairncross JG: Supratentorial anaplastic gliomas in adults - the prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71: 487-493, 1989.
22. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR. Pardo FS, Weisskoff RM, Harsh GR, Cosgrove CR, Halpern EF, Hochberg FH and Rosen BR: Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings. Radiology 191: 41-51, 1994.
23. Preul M, Caramanos, Z, Collins DL, Villemure J-G, Feindel W and Arnold D: Linear discriminant analysis based on proton MR spectroscopic imaging of human brain tumours improves preoperative diagnosis. Proc Soc Magn Reson 2: 125, 1994.
24. Sijens PE, Knopp MV, Brunetti A, Wicklow K, Alfano B, Bachert P, Sanders JA, Stillman AE, Kett H, Sauter R, Oudkerk M: IH MR spectroscopy in patients with metastatic brain tumors: a multicenter study. Magn Reson Med 33: 818-826, 1995.
25. Morantz RA: Management of low-grade cerebral astrocytomas, in Morantz, RA, Walsh JW (eds): Brain Tumors. New York: Marcel-Dekker, 387-415, 1994.